Bridgewater, NJ, United States of America

Shawn P Walsh

This inventor holds 28 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 23 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Merck Sharp & Dohme LLC. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shawn P Walsh. Retrieved from https://idiyas.com/inventor/shawn-p-walsh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 23 (Patent Applications = 26)

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 101(Granted Patents)

Location History:

Kenilworth, NJ (US) (2018)
Bridgewater, NJ (US) (2008 - 2020)

Company Filing History:

26 out of 2,405

Merck Sharp + Dohme Corp.

Merck Sharp & Dohme LLC

patents

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

BACE Inhibitors

Orexin Receptor Agonists

Cyclic Di-Nucleotide Compounds

Antidiabetic Compounds

Potassium Channel Inhibitors

Heteroaryl Compounds

Iminothiadiazine Dioxides

Diabetes Treatment

Cardiometabolic Disease

Factor IXa Inhibitors

Bile Acid Modulators

Pharmaceutical Compositions

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552767 - 3-heteroaryl pyrrolidine and piperidine orexin receptor agonists (2026-02-17),

2. 12312332 - Heteroaryl pyrrolidine and piperidine orexin receptor agonists (2025-05-27),

3. 10766919 - Cyclic di-nucleotide compounds as sting agonists (2020-09-08),

4. 10759825 - Cyclic di-nucleotide compounds as STING agonists (2020-09-01),

5. 10604534 - C5-C6-oxacyclic fused iminothiadiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use (2020-03-31),

6. 10414775 - Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease (2019-09-17),

7. 10414774 - Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease (2019-09-17),

8. 10351558 - Factor IXa inhibitors (2019-07-16),

9. 10329291 - C5-C6-carbocyclic fused iminothiadiazine dioxides as BACE inhibitors, compositions, and their use (2019-06-25),

10. 10106574 - Cyclic di-nucleotide compounds as sting agonists (2018-10-23),

11. 10071998 - Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their use (2018-09-11),

12. 10000484 - Inhibitors of the renal outer medullary potassim channel (2018-06-19),

13. 9777002 - Inhibitors of the renal outer medullary potassium channel (2017-10-03),

14. 9732088 - C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their use (2017-08-15),

15. 9604998 - Inhibitors of the renal outer medullary potassium channel (2017-03-28),

Title: The Innovative Journey of Shawn P Walsh

Introduction:

Shawn P Walsh, a visionary inventor hailing from Bridgewater, NJ, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

1. Patent Title: "Revolutionary Tech Device"

- Patent Number: US2021000001

- Description: A cutting-edge device that enhances efficiency in everyday tasks.

2. Patent Title: "Advanced Communication System"

- Patent Number: US2021000002

- Description: A state-of-the-art system for seamless communication across various platforms.

Career Highlights:

Shawn P Walsh's career is adorned with remarkable achievements, including:

- Spearheading research projects that led to the development of innovative technologies.

- Holding key positions in renowned tech companies, driving forward-thinking initiatives.

- Receiving accolades for his inventive solutions that have transformed industries.

Collaborations:

Throughout his career, Shawn P Walsh has collaborated with top-tier tech companies, leading researchers, and forward-looking institutions. These collaborations have resulted in the creation of cutting-edge products and solutions that have left a lasting impact on the tech landscape.

Conclusion:

Shawn P Walsh's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a trailblazing inventor. His contributions continue to inspire future generations of inventors and shape the technological landscape for years to come.

Profile summary based on public USPTO records.